Topical vs Oral Finasteride: Evidence, Finjuve, and Side Effects

Topical finasteride has shown benefit in some men with androgenetic alopecia, but it is not free of systemic risks. A trial of a particular spray found lower blood exposure than oral treatment, not zero absorption. Check the product's approved population, directions, and precautions against transferring it to someone else.^trialfda

AI-generated editorial illustration; not a photograph of a patient, product, or treatment result.

What differs when the active ingredient is the same?

Both routes use finasteride, but the topical formulation is applied to the scalp and was studied at a different dose and in a different formulation from tablets. Equal amounts cannot simply be substituted, and application to the scalp does not mean the drug acts only there.^trial

Feature	What to check with topical treatment
Route	A specified scalp product rather than a swallowed tablet
Systemic exposure	Lower in a particular trial formulation, but not absent
Evidence	Applies to the studied formulation, dose, vehicle, and duration
Practical precautions	Scalp irritation and transfer to other people

Lower exposure may be an advantage to discuss. It does not establish that every topical preparation is safer than tablets. A commercial spray, a compounded preparation, and a minoxidil combination require separate consideration.^fda

What did clinical trials find?

A European phase III randomized trial published in 2022 treated adult men for 24 weeks. The topical group gained more hairs in the measured scalp area than the placebo group. Results were numerically similar to the oral group, but that does not prove equivalent efficacy for every patient.^trial

A Chinese phase III trial, published online in 2025, compared a particular spray with placebo in 270 men over 24 weeks. Hair-count change favored the spray at week 24. This did not establish long-term safety or efficacy for other compounded concentrations.^china

Controlled trials provide stronger evidence than testimonials, but limited follow-up and selected populations cannot exclude rare adverse effects or justify extending results to women or children.^trialchina

Who is Finjuve intended for in South Korea?

The Boryung product information checked on October 4, 2026 lists mild to moderate male androgenetic alopecia in adult men aged 18–41 years. It describes scalp-only application and an expected assessment period of three to six months. Do not increase the number of sprays to chase faster results.^boryung

An online account may concern someone outside the labeled population. Women's crown thinning requires its own assessment; see Female Pattern Hair Loss.

Does topical use eliminate sexual side effects?

No such guarantee can be made. A 2025 FDA alert described adverse-event reports involving compounded topical finasteride and noted expected skin absorption. Reports cannot establish an incidence rate or prove causation in each case, but they challenge claims that topical treatment has no adverse effects.^fda

The alert concerns U.S. compounded products. The absence of an FDA-approved topical formulation in the United States should not be confused with a Korean product's regulatory status.^fdaboryung

Tell the prescriber about sexual symptoms or persistent irritation, with the product name and onset date. The Korean product information also instructs patients to stop treatment and seek medical advice if psychiatric symptoms such as depressed mood occur. Seek urgent medical help for thoughts of self-harm or an immediate danger.^label

See Finasteride, Dutasteride, and Sexual Function for related evidence.

What about contact with family members and other medicines?

The Korean information excludes use in women and children and warns that anyone pregnant or potentially pregnant should avoid contact with the solution or exposed scalp and surfaces. Wash the affected skin thoroughly after accidental contact.^label

It also restricts use alongside oral finasteride or other topical medicines on the same area, noting that combination with topical minoxidil has not been evaluated. Do not layer or mix products yourself. Research or testimonials about an overseas compounded combination do not replace directions for this product.^label

Questions to ask before a prescription

1. Does my diagnosis and age match this product's labeled population?
2. Why consider this formulation instead of a tablet?
3. How should my existing minoxidil or other medicines be handled?
4. Which contact precautions in the leaflet matter for my household?
5. Which symptoms mean stopping treatment or contacting you sooner?
6. When will photographs and examination be used to reassess benefit?

Changing route is different from switching brands of the same oral medicine. See Propecia vs Generic Finasteride for that separate question.

Seek dermatologic evaluation before choosing treatment if loss is sudden, patchy, painful, scarring, or rapidly worsening.^aad

Sources